Tag Archives: Reuters

Update: Where does Brexit leave European pharma, now that the EU has excluded the UK from drug approvals?

A European decision to exclude Britain from the EU’s drug approval system from beginning 30, 2019–the day after Brexit–has raised alarm among drugmakers, who fear the abrupt change could disrupt… Read more »

Insys attempting “Phoenix” impersonation as key Q1 earnings slated for Tuesday. Analysts say Buy, but is now the time?

The News: A former Insys Therapeutics Inc. (Chandler AZ) sales representative was recently sentenced to six months of home confinement after admitting that she participated in a scheme to pay… Read more »

US citizen denied life-saving bone-marrow transplant from Iranian brother due to Trump travel ban. My very brief take.

The News: Maziar Hashemi, a naturalized US citizen who has lived in the US since the 1970s, has been told by doctors that his best hope for surviving a rare… Read more »

New study says family history increases breast-cancer risk, even among older women. US mammogram guidelines need updating–soon.

The News: Women are more likely to develop breast cancer when a mother or sister had this disease, and the risk associated with family history doesn’t diminish regardless of age,… Read more »

Physician burnout, suicide take a toll on everyone, and it’s getting worse. What’s the answer?

The News: Nearly two-thirds of US doctors feel burned out, depressed, or both–and those feelings affect how they relate to patients, according to a survey conducted by Medscape. “One in… Read more »

Ablynx soars 60% on Novo’s latest hostile bid; grab a piece of this Belgian biotech because the real action’s just starting.

The News: Denmark’s Novo Nordisk A/S (Copenhagen), the world’s biggest insulin maker, went public Monday (January 8, 2018) with a €2.6-billion ($3.1 billion) bid for Belgian biotech group Ablynx NV… Read more »

Alarming Harvard study predicts over half of US children will be obese by age 35. Time to embrace the “Nanny State?”

The News: Nearly three in five children in the US today are destined to be obese when they reach their 35th birthday, according to a new projection that Reuters reports…. Read more »

Pfizer, Merck’s Bavencio flop illustrative of shattered Pharma model. Is industry’s collapse just around the corner?

The News: Pfizer Inc. (NYC) and its German part­ner Merck KGaA (Darmstadt) have run into a brick wall in their race to ex­pand the mar­ket for their PD-L1 check­point inhibitor Baven­cio… Read more »

Trump does end-run around Congress, scraps Obamacare insurer subsidies via executive order; what’s really happening?

The News: An alliance of US states joined ranks on Friday (October 13, 2017) to sue to block President Donald Trump’s move to dump a key component of Obamacare–subsidies to… Read more »